Inventor
Alan P. Kozikowski
Inventor
Princeton, NJ, US
Overview
Patents· 84 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry3%
C07HSugars2%
C07KPeptides1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,973,819Small molecules inhibitors of RAD51202110,934,255Nrf and HIF activators/HDAC inhibitors and therapeutic methods using the same202110,912,761Methods and compositions involving RAD51 inhibitors202110,836,733HDAC inhibitors and therapeutic methods using the same202010,456,394Tetrahydroquinoline substituted hydroxamic acids as selective histone deacetylase 6 inhibitors201910,407,381Cyclopropylmethanamines as selective 5-HT(2C) receptor agonists201910,227,295Selective histone deactylase 6 inhibitors2019RE047009HDAC inhibitors and therapeutic methods using the same20189,956,192Selective histone deactylase 6 inhibitors20189,751,832'Selective histone deactylase 6 inhibitors'20179,409,858'Selective histone deactylase 6 inhibitors'20169,249,087'HDAC inhibitors and therapeutic methods using the same'20168,754,132'Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor'20148,748,463'Histone deacetylase inhibitors and methods of use thereof'20148,748,451'HDAC inhibitors and therapeutic methods of using same'20148,653,278'Isoform selective HDAC inhibitors'20148,609,721'Ligands for metabotropic glutamate receptors and inhibitors of NAALADase'20138,492,591'Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor'20138,445,684'Nicotinic acetylcholine receptor ligands and the uses thereof'20138,431,538'HDAC inhibitors and therapeutic methods of using same'20138,227,634'Imaging agents and methods of imaging NAALADase or PSMA'20128,222,451'Histone deacetylase inhibitors and methods of use thereof'20128,207,216'Benzofuran-3-yl(indol-3-yl) maleimides as potent GSK3 inhibitors'20128,153,657'Dopamine-, norepinephrine- and serotonin-transporter-selective heterocyclic compounds and their therapeutic applications'20128,067,600'Histone deacetylase inhibitors and methods of use thereof'20118,044,103'Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders'20118,030,300'Ligands for nicotinic acetylcholine receptors, and methods of making and using them'20117,842,835'Histone deacetylase inhibitors and methods of use thereof'20107,507,831'Tetra- and penta-o-benzyl-protected, C-4 activated-epicatechin and -catechin monomers and processes for their preparation and use'20097,507,828'Histone deacetylase inhibitors and methods of use thereof'20097,408,079'Imaging agents and methods of imaging NAALADase or PSMA'20087,381,745'Ligands for metabotropic glutamate receptors and inhibitors of NAALADase'20087,378,403'Akt inhibitors, pharmaceutical compositions, and uses thereof'20087,268,240'Synthetic methods for polyphenols'20077,244,855'Synthesis of oligomeric epicatechin and catechin-derived procyanidins'20077,202,279'Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders'20077,153,843'Inhibitors of phosphatidyl myo-inositol cycle'20067,126,014'Synthesis of epecatechin-4α, 8-epicatechin and -catechin dimers and derivatives thereof'20067,067,679'Synthesis of dimeric, trimeric, tetrameric pentameric, and higher oligomeric epicatechin-derived procyanidins having 4,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest'20066,982,271'Tropane analogs'20066,849,746'Synthetic methods for polyphenols'20056,825,211'Bicyclic metabotropic glutamate receptor ligands'20046,806,281'Analogs of cocaine'20046,720,432'Synthesis of epecatechin-4, 8-epicatechin dimers and derivatives thereof'20046,667,340'Inhibitors of phosphatidyl myo-inositol cycle'20036,624,151'Compounds selectively inhibiting gamma 9 delta 2 T lymphocytes'20036,610,743'Bicyclic metabotropic glutamate receptor ligands'20036,605,621'Monomeric and dimeric heterocycles, and therapeutic uses thereof'20036,599,940'Synthesis of 2-hydroxymethylglutamic acid and congeners thereof'20036,528,499'Ligands for metabotropic glutamate receptors and inhibitors of NAALADase'20036,528,664'Synthetic methods for polyphenols'20036,479,470'Ligands for metabotropic glutamate receptors and inhibitors of NAALAdase'20026,476,241'Synthesis of 4-arylepicatechins'20026,472,422'Analogs of cocaine'20026,440,996'Monomeric and dimeric heterocycles, and therapeutic uses thereof'20026,420,572'Synthetic methods for preparation of protected proanthocyanidin(s)'20026,376,532'Bicyclic metabotropic glutamate receptor ligands'20026,369,052'Combination of huperzine and nicotinic compounds as a neuroprotective agent'20026,350,758'Tropane derivatives and method for their synthesis'20026,284,784'Substituted 2-pyrrolidinone activators of PKC'20016,271,379'Intermediates useful for the synthesis of huperzine A'20016,245,754'Inhibitors of phosphatidyl myo-inositol cycle'20016,207,842'Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives'20016,204,292'Bicyclic metabotropic glutamate receptor ligands'20016,180,648'Analogs of cocaine'20016,156,912'88, 66, and 68 catechin and epicatechin dimers and methods for their preparation'20006,150,376'Bi- and tri-cyclic aza compounds and their uses'20006,143,740'Heregulin antagonists and methods for their use'20005,962,504'Substituted 2-pyrrolidinone activators of PKC'19995,869,672'Huperzine A and analogs thereof'19995,663,344'Method for the synthesis of huperzine A and analogs thereof and compounds useful therein'19975,547,960'C-10 analogs of huperzine a'19965,391,744'Cocaine analogs'19955,268,480'Cocaine analogs'19935,227,508'3-deoxy-3-substituted analogs of phosphatidylinositol'19935,210,263'Inositol phosphate analogs and methods for their use'19935,206,382'Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders'19935,132,313'Non-competitive NMDA receptor antagonists and methods for their use'19925,106,979'Method for the synthesis of huperzine A and analogs thereof and compounds useful therein'19925,104,880'Huperzine a analogs as acetylcholinesterase inhibitors'19925,053,399'Myo-inositol analogs and methods for their use'19914,990,504'Azetidine derivatives to treat memory and learning disorders'19914,988,682'Myo-inositol analogs and method for their use'19914,929,731'Method for the synthesis of huperzine A and analogs thereof and compounds useful therein'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1999Based in Pittsburgh, PA, US· patent location history
1991–1995Based in Ponte Vedra Beach, FL, US· patent location history
1992–1999Patents assigned to MAYO FOUNDATION (8)· patent assignee history
1996–2013Based in Princeton, NJ, US· patent location history
1999–2014Patents assigned to UNIV GEORGETOWN (33)· patent assignee history
2000–2009Patents assigned to MARS INC (12)· patent assignee history
2006–2021Based in Chicago, IL, US· patent location history
2010Based in Arlington, VA, US· patent location history
2011–2014Patents assigned to KOZIKOWSKI ALAN P (9)· patent assignee history
2012–2021Patents assigned to UNIV ILLINOIS (11)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV GEORGETOWN | 33 | 1999–2014 |
| MARS INC | 12 | 2000–2009 |
| UNIV ILLINOIS | 11 | 2012–2021 |
| KOZIKOWSKI ALAN Pself | 9 | 2011–2014 |
| MAYO FOUNDATION | 8 | 1992–1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Princeton, New Jersey, US | 40 | 1996–2013 |
| Chicago, Illinois, US | 29 | 2006–2021 |
| Ponte Vedra Beach, Florida, US | 8 | 1991–1995 |
| Pittsburgh, Pennsylvania, US | 6 | 1990–1999 |
| Arlington, Virginia, US | 1 | 2010 |